|
WO2004098560A1
|
|
Implants for non-radioactive brachytherapy of hormonal-insensitive cancers
|
|
US2005245457A1
|
|
Pseudopeptides growth hormone secretagogues
|
|
AU4371799A
|
|
Lysine containing peptides for treatment of heart disease
|
|
US5945128A
|
|
Process to manufacture implants containing bioactive peptides
|
|
WO9722620A1
|
|
Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
|
|
AU6700996A
|
|
Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
|
|
ZA9507977B
|
|
Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
|
|
ITMI951293D0
|
|
Polypeptide compounds containing D-2-alkyl tryptophane capable of promoting the release of growth hormone
|
|
EP0719148A1
|
|
Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
|
|
US5668254A
|
|
D-2-alkyl-tryptophan and peptides containing same
|
|
AU1371892A
|
|
Luteinizing hormone releasing hormone antagonist peptides
|
|
KR100210472B1
|
|
Luteinizing hormone releasing hormone antagonist peptides
|
|
WO9118016A1
|
|
Biologically active peptides containing d-2-alkyltryptophan
|
